Triazolam (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Triazolam" in English language version.
refsWebsite
Global rank
English rank
1st place
1st place
11th place
8th place
low place
low place
low place
low place
3,600th place
2,528th place
621st place
380th place
3rd place
3rd place
3,912th place
2,496th place
low place
low place
low place
low place
low place
low place
low place
low place
atripla.com
- "Medicines You Should Not Take with Atripla". Bristol-Myers Squibb & Gilead Sciences, LLC. 2008. Archived from the original on 25 April 2010. Retrieved 3 January 2010.
bcnc.org.uk
- Professor heather Ashton (April 2007). "Benzodiazepine equivalency table". Archived from the original on 28 September 2007. Retrieved 23 September 2007.
books.google.com
- Shorter E (2005). "B". A Historical Dictionary of Psychiatry. Oxford University Press. ISBN 9780190292010.
clincalc.com
- "Triazolam - Drug Usage Statistics". ClinCalc. Retrieved 7 October 2022.
dentistrytoday.com
- "Comparison of Triazolam and Zaleplon for Sedation of Dental Patient". Dentistry Today. September 2005. Archived from the original on 1 January 2019. Retrieved 6 January 2019.
doi.org
- Mandrioli R, Mercolini L, Raggi MA (October 2008). "Benzodiazepine metabolism: an analytical perspective". Current Drug Metabolism. 9 (8): 827–844. doi:10.2174/138920008786049258. PMID 18855614.
- Vermeeren A (2004). "Residual effects of hypnotics: epidemiology and clinical implications". CNS Drugs. 18 (5): 297–328. doi:10.2165/00023210-200418050-00003. PMID 15089115. S2CID 25592318.
- Kirkwood CK (1999). "Management of insomnia". Journal of the American Pharmaceutical Association. 39 (5): 688–96, quiz 713–4. doi:10.1016/S1086-5802(15)30354-5. PMID 10533351.
- Kales A, Scharf MB, Kales JD, Soldatos CR (April 1979). "Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines". JAMA. 241 (16): 1692–1695. doi:10.1001/jama.241.16.1692. PMID 430730.
- Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, et al. (November 2009). "Benzodiazepine dependence: focus on withdrawal syndrome". Annales Pharmaceutiques Françaises. 67 (6): 408–413. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.
- Mets MA, Volkerts ER, Olivier B, Verster JC (August 2010). "Effect of hypnotic drugs on body balance and standing steadiness". Sleep Medicine Reviews. 14 (4): 259–267. doi:10.1016/j.smrv.2009.10.008. PMID 20171127.
- Bayer AJ, Bayer EM, Pathy MS, Stoker MJ (1986). "A double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly". Acta Psychiatrica Scandinavica. Supplementum. 329 (suppl 329): 104–111. doi:10.1111/j.1600-0447.1986.tb10544.x. PMID 3529832. S2CID 24226217.
- Bain KT (June 2006). "Management of chronic insomnia in elderly persons". The American Journal of Geriatric Pharmacotherapy. 4 (2): 168–192. doi:10.1016/j.amjopharm.2006.06.006. PMID 16860264.
- Varhe A, Olkkola KT, Neuvonen PJ (December 1994). "Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole". Clinical Pharmacology and Therapeutics. 56 (6 Pt 1): 601–607. doi:10.1038/clpt.1994.184. PMID 7995001. S2CID 39127216.
- Tokinaga N, Kondo T, Kaneko S, Otani K, Mihara K, Morita S (December 1996). "Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin". Psychiatry and Clinical Neurosciences. 50 (6): 337–339. doi:10.1111/j.1440-1819.1996.tb00577.x. PMID 9014234. S2CID 22742117.
- Mattila ME, Mattila MJ, Nuotto E (April 1992). "Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects". Pharmacology & Toxicology. 70 (4): 286–289. doi:10.1111/j.1600-0773.1992.tb00473.x. PMID 1351673.
- Wang JS, DeVane CL (2003). "Pharmacokinetics and drug interactions of the sedative hypnotics" (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. S2CID 1543185. Archived from the original (PDF) on 9 July 2007.
- Kudo K, Imamura T, Jitsufuchi N, Zhang XX, Tokunaga H, Nagata T (April 1997). "Death attributed to the toxic interaction of triazolam, amitriptyline and other psychotropic drugs". Forensic Science International. 86 (1–2): 35–41. doi:10.1016/S0379-0738(97)02110-5. PMID 9153780.
- Chweh AY, Swinyard EA, Wolf HH, Kupferberg HJ (February 1985). "Effect of GABA agonists on the neurotoxicity and anticonvulsant activity of benzodiazepines". Life Sciences. 36 (8): 737–744. doi:10.1016/0024-3205(85)90193-6. PMID 2983169.
drugs.com
- "Triazolam (Halcion) Use During Pregnancy". Drugs.com. 18 September 2020. Retrieved 24 October 2020.
fda.gov
fda.gov
- "FDA expands Boxed Warning to improve safe use of benzodiazepine drug". U.S. Food and Drug Administration (FDA). 23 September 2020. Retrieved 23 September 2020.
This article incorporates text from this source, which is in the public domain. - "Halcion triazolam tablets" (PDF). www.fda.gov. Archived from the original (PDF) on 6 November 2003. Retrieved 15 January 2022.
nctr-crs.fda.gov
- "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.
icliniq.com
- "What Is Triazolam Used For?". www.icliniq.com. 1 November 2022. Retrieved 30 January 2023.
in.gov.br
- Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.
incb.org
- "List of psychotropic substances under international control" (PDF). Green list. International Narcotics Control Board. Archived from the original (PDF) on 31 August 2012. Retrieved 23 March 2006.
medworksmedia.com
- Wang JS, DeVane CL (2003). "Pharmacokinetics and drug interactions of the sedative hypnotics" (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. S2CID 1543185. Archived from the original (PDF) on 9 July 2007.
nih.gov
pubmed.ncbi.nlm.nih.gov
- Mandrioli R, Mercolini L, Raggi MA (October 2008). "Benzodiazepine metabolism: an analytical perspective". Current Drug Metabolism. 9 (8): 827–844. doi:10.2174/138920008786049258. PMID 18855614.
- Mauri MC, Gianetti S, Pugnetti L, Altamura AC (1993). "Quazepam versus triazolam in patients with sleep disorders: a double-blind study". International Journal of Clinical Pharmacology Research. 13 (3): 173–177. PMID 7901174.
- Vermeeren A (2004). "Residual effects of hypnotics: epidemiology and clinical implications". CNS Drugs. 18 (5): 297–328. doi:10.2165/00023210-200418050-00003. PMID 15089115. S2CID 25592318.
- Lieberherr S, Scollo-Lavizzari G, Battegay R (June 1991). "[Confusional states following administration of short-acting benzodiazepines (midazolam/triazolam)]". Schweizerische Rundschau für Medizin Praxis. 80 (24): 673–675. PMID 2068441.
- Kirkwood CK (1999). "Management of insomnia". Journal of the American Pharmaceutical Association. 39 (5): 688–96, quiz 713–4. doi:10.1016/S1086-5802(15)30354-5. PMID 10533351.
- Kales A, Scharf MB, Kales JD, Soldatos CR (April 1979). "Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines". JAMA. 241 (16): 1692–1695. doi:10.1001/jama.241.16.1692. PMID 430730.
- Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, et al. (November 2009). "Benzodiazepine dependence: focus on withdrawal syndrome". Annales Pharmaceutiques Françaises. 67 (6): 408–413. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.
- Mets MA, Volkerts ER, Olivier B, Verster JC (August 2010). "Effect of hypnotic drugs on body balance and standing steadiness". Sleep Medicine Reviews. 14 (4): 259–267. doi:10.1016/j.smrv.2009.10.008. PMID 20171127.
- Bayer AJ, Bayer EM, Pathy MS, Stoker MJ (1986). "A double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly". Acta Psychiatrica Scandinavica. Supplementum. 329 (suppl 329): 104–111. doi:10.1111/j.1600-0447.1986.tb10544.x. PMID 3529832. S2CID 24226217.
- Bain KT (June 2006). "Management of chronic insomnia in elderly persons". The American Journal of Geriatric Pharmacotherapy. 4 (2): 168–192. doi:10.1016/j.amjopharm.2006.06.006. PMID 16860264.
- Varhe A, Olkkola KT, Neuvonen PJ (December 1994). "Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole". Clinical Pharmacology and Therapeutics. 56 (6 Pt 1): 601–607. doi:10.1038/clpt.1994.184. PMID 7995001. S2CID 39127216.
- Tokinaga N, Kondo T, Kaneko S, Otani K, Mihara K, Morita S (December 1996). "Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin". Psychiatry and Clinical Neurosciences. 50 (6): 337–339. doi:10.1111/j.1440-1819.1996.tb00577.x. PMID 9014234. S2CID 22742117.
- Mattila ME, Mattila MJ, Nuotto E (April 1992). "Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects". Pharmacology & Toxicology. 70 (4): 286–289. doi:10.1111/j.1600-0773.1992.tb00473.x. PMID 1351673.
- Wang JS, DeVane CL (2003). "Pharmacokinetics and drug interactions of the sedative hypnotics" (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. S2CID 1543185. Archived from the original (PDF) on 9 July 2007.
- Arayne MS, Sultana N, Bibi Z (October 2005). "Grape fruit juice-drug interactions". Pakistan Journal of Pharmaceutical Sciences. 18 (4): 45–57. PMID 16380358.
- Kudo K, Imamura T, Jitsufuchi N, Zhang XX, Tokunaga H, Nagata T (April 1997). "Death attributed to the toxic interaction of triazolam, amitriptyline and other psychotropic drugs". Forensic Science International. 86 (1–2): 35–41. doi:10.1016/S0379-0738(97)02110-5. PMID 9153780.
- Oelschläger H (July 1989). "[Chemical and pharmacologic aspects of benzodiazepines]". Schweizerische Rundschau für Medizin Praxis. 78 (27–28): 766–772. PMID 2570451.
- Chweh AY, Swinyard EA, Wolf HH, Kupferberg HJ (February 1985). "Effect of GABA agonists on the neurotoxicity and anticonvulsant activity of benzodiazepines". Life Sciences. 36 (8): 737–744. doi:10.1016/0024-3205(85)90193-6. PMID 2983169.
- Griffiths RR, Johnson MW (2005). "Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds". The Journal of Clinical Psychiatry. 66 (Suppl 9): 31–41. PMID 16336040.
dailymed.nlm.nih.gov
- "Halcion- triazolam tablet". DailyMed. 10 December 2019. Retrieved 23 October 2020.
non-benzodiazepines.org.uk
- "Benzodiazepine Names". non-benzodiazepines. Archived from the original on 8 December 2008. Retrieved 29 December 2008.
semanticscholar.org
api.semanticscholar.org
- Vermeeren A (2004). "Residual effects of hypnotics: epidemiology and clinical implications". CNS Drugs. 18 (5): 297–328. doi:10.2165/00023210-200418050-00003. PMID 15089115. S2CID 25592318.
- Bayer AJ, Bayer EM, Pathy MS, Stoker MJ (1986). "A double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly". Acta Psychiatrica Scandinavica. Supplementum. 329 (suppl 329): 104–111. doi:10.1111/j.1600-0447.1986.tb10544.x. PMID 3529832. S2CID 24226217.
- Varhe A, Olkkola KT, Neuvonen PJ (December 1994). "Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole". Clinical Pharmacology and Therapeutics. 56 (6 Pt 1): 601–607. doi:10.1038/clpt.1994.184. PMID 7995001. S2CID 39127216.
- Tokinaga N, Kondo T, Kaneko S, Otani K, Mihara K, Morita S (December 1996). "Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin". Psychiatry and Clinical Neurosciences. 50 (6): 337–339. doi:10.1111/j.1440-1819.1996.tb00577.x. PMID 9014234. S2CID 22742117.
- Wang JS, DeVane CL (2003). "Pharmacokinetics and drug interactions of the sedative hypnotics" (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. S2CID 1543185. Archived from the original (PDF) on 9 July 2007.
ualberta.ca
redpoll.pharmacy.ualberta.ca
- Wishart, David (2006). "Triazolam". DrugBank. Retrieved 23 March 2006.
web.archive.org
- Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.
- "Benzodiazepine Names". non-benzodiazepines. Archived from the original on 8 December 2008. Retrieved 29 December 2008.
- "Comparison of Triazolam and Zaleplon for Sedation of Dental Patient". Dentistry Today. September 2005. Archived from the original on 1 January 2019. Retrieved 6 January 2019.
- "Halcion triazolam tablets" (PDF). www.fda.gov. Archived from the original (PDF) on 6 November 2003. Retrieved 15 January 2022.
- Wang JS, DeVane CL (2003). "Pharmacokinetics and drug interactions of the sedative hypnotics" (PDF). Psychopharmacology Bulletin. 37 (1): 10–29. doi:10.1007/BF01990373. PMID 14561946. S2CID 1543185. Archived from the original (PDF) on 9 July 2007.
- "Medicines You Should Not Take with Atripla". Bristol-Myers Squibb & Gilead Sciences, LLC. 2008. Archived from the original on 25 April 2010. Retrieved 3 January 2010.
- Professor heather Ashton (April 2007). "Benzodiazepine equivalency table". Archived from the original on 28 September 2007. Retrieved 23 September 2007.
- "List of psychotropic substances under international control" (PDF). Green list. International Narcotics Control Board. Archived from the original (PDF) on 31 August 2012. Retrieved 23 March 2006.
zenodo.org
- Mandrioli R, Mercolini L, Raggi MA (October 2008). "Benzodiazepine metabolism: an analytical perspective". Current Drug Metabolism. 9 (8): 827–844. doi:10.2174/138920008786049258. PMID 18855614.